Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chordoma × nilotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 40 Leukemia, Myeloid, Chronic-Phase 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia 5 Blast Crisis 5 Neoplasm Metastasis 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Gastrointestinal Stromal Tumors 3 Synovitis, Pigmented Villonodular 2 Recurrence 2 Leukemia, Myeloid, Accelerated Phase 2 Substance Withdrawal Syndrome 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Neoplasms 1 Neoplasm, Residual 1 Mucosal Lentiginous Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Head and Neck Neoplasms 1 Glioma 1 Giant Cell Tumor of Tendon Sheath 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Chordoma 1 Carcinoma, Squamous Cell 1

Interventions

Nivolumab 5 palbociclib 2 Radiosurgery 2 Protons 2 Proton Therapy 2 Pemetrexed 2 Ipilimumab 2 Imatinib Mesylate 2 tazemetostat 1 relatlimab 1 pembrolizumab 1 nilotinib 1 camrelizumab 1 apatinib 1 Zoledronic Acid 1 Thiotepa 1 Surveys and Questionnaires 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Photochemotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Melphalan 1 Mastectomy, Segmental 1 Immunoglobulin G 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Disulfides 1 Dihematoporphyrin Ether 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01407198 2025-12-19

Nilotinib With Radiation for High Risk Chordoma

Massachusetts General Hospital

Phase 1 Completed

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡